SI-BONE Inc
NASDAQ:SIBN

Watchlist Manager
SI-BONE Inc Logo
SI-BONE Inc
NASDAQ:SIBN
Watchlist
Price: 14.04 USD 0.07% Market Closed
Market Cap: 596m USD

SI-BONE Inc
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SI-BONE Inc
Total Other Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
SI-BONE Inc
NASDAQ:SIBN
Total Other Income
-$73k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Total Other Income
-$39m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Total Other Income
-$16m
CAGR 3-Years
-21%
CAGR 5-Years
N/A
CAGR 10-Years
-9%
Stryker Corp
NYSE:SYK
Total Other Income
$60m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbott Laboratories
NYSE:ABT
Total Other Income
$558m
CAGR 3-Years
26%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Intuitive Surgical Inc
NASDAQ:ISRG
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

SI-BONE Inc
Glance View

Economic Moat
None
Market Cap
590.9m USD
Industry
Health Care

SI-BONE, Inc. engages in the provision of implantable devices used in the surgical treatment of the sacropelvic anatomy. The company is headquartered in Santa Clara, California and currently employs 352 full-time employees. The company went IPO on 2018-10-17. The firm is focused on the development of implantable devices used in the surgical treatment of sacro-pelvic anatomy. Its invasive surgical implant system, iFuse, is used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. Its iFuse Implant System includes a series of triangular titanium implants and the instruments developed to enable surgeons to perform the procedure. Its iFuse system, which includes its implants and instruments, is designed to address the shortcomings of alternative treatments, including open surgery, non-surgical management, and screw-based and other minimally invasive stabilization and fusion procedures. Its iFuse-3D design allows the surgeons to fill the implant with ground-up bone before implantation, which accelerates bone through-growth and biological fixation. The company also provides other technologies for its surgeons other than iFuse and iFuse-3D.

SIBN Intrinsic Value
21.16 USD
Undervaluation 34%
Intrinsic Value
Price

See Also

What is SI-BONE Inc's Total Other Income?
Total Other Income
-73k USD

Based on the financial report for Dec 31, 2024, SI-BONE Inc's Total Other Income amounts to -73k USD.

Back to Top